Organigram Holdings Inc. Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending August 31, 2022 was 105.15% (a 123.82% increase compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 63.25%
  • Annual Research and Development (R&D) Expenses Growth for 2022 was 71.19% (a -61.03% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 182.66% (a -15.05% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 215.01% (a -415.03% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending August 31, 2022 was 69.84% (a -6.77% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -52.01% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
31 Aug '22 31 May '22 28 Feb '22 30 Nov '21
69.84% 74.91% 122.43% 145.53%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Organigram Holdings Inc.

Most recent Research and Development (R&D) Expenses Growthof OGI including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Organigram Holdings Inc.

Organigram Holdings Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 105.15% 46.98% 49.45% 71.19%
2021 64.41% 221.43% 482.48% 75.45% 182.66%
2020 -39.18% -68.89% -82.83% -43.0% 215.01%
2019 -68.25%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic